WSJ: Theranos settles Walgreens lawsuit for $30 million

09:55 EDT 22 Jun 2017 | Drug Store News

Walgreens Boots Alliance and Theranos have tentatively reached accord on a $30 million agreement, according to a story published Wednesday in The Wall Street Journal. Walgreens had been seeking $140 million as part of a breach of conctract suit in an attempt to recover the cost of its investment. According to reports, Theranos recently told investors it had about $54 million in cash left to settle suits, down from $187 million in January. (The Wall Street Journal)

Original Article: WSJ: Theranos settles Walgreens lawsuit for $30 million


More From BioPortfolio on "WSJ: Theranos settles Walgreens lawsuit for $30 million"

Quick Search


Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...